American Healthcare REIT - Q3 2026 Earnings Conference Call - AMERICAN HEALTHCARE REIT INC

Financial Performance:

• Same-store NOI grew 13.8% YoY (11th consecutive double-digit quarter), with Trilogy growing 15.7% and Shop segment accelerating to 28.2% YoY growth.
• Reported normalized FFO of $0.58 per diluted share, a 31.8% increase YoY.
• Same-store NOI margins expanded significantly: Shop segment margins rose 350 bps to 23.5%, and Trilogy margins improved 200 bps to 21%.
• Net debt to EBITDA stands at 1.9x, down 0.5x sequentially and 1.6x from the prior year.
• Same-store revenue grew 4.8% at Trilogy (driven by 75.5% quality mix) and 9% at Shop (driven by 5.4% RevPOR growth and a 460 bps spread between RevPOR and expense growth).
• Controllable operating expenses at Trilogy declined 3.7% YoY due to efficiency in employee benefits and operational optimization.

Guidance and Future Outlook:

• Raised full-year 2026 NFFO per diluted share guidance to $2.23–$2.26 (previously $2.15–$2.19), implying >30% YoY growth.
• Raised full-year same-store NOI growth guidance to 12–14% (previously 11–13% midpoint).
• Segment-specific NOI growth guidance updated: Trilogy (14.5–16.5%), Shop (23–26%), Outpatient Medical (0.5–1%), Triple Net (2.5–3.5%).
• Q4 guidance implies a repeat of Q3's high single-digit to low double-digit NOI performance growth.
• Management expects continued RevPOR acceleration and occupancy growth into 2027, fueled by the incoming baby boomer generation.

Business Segments and Product Lines:

• Trilogy (Post-Acute/Skilled Nursing): Occupancy reached 91.2% (up 110 bps YoY), with skilled nursing occupancy rising to 90.2% despite seasonal headwinds; CMS star ratings average 4.2, industry-leading.
• Shop (Senior Housing): Portfolio expanded to 109 properties and 10,000+ units; average vintage improved to 18.1 years (from 22.9 years).
• New Hires: Eric Chang joined as CFO; Ann Lacey (EVP Portfolio & Asset Management) and John Crozier (CTO) were hired to enhance asset management and technology/data capabilities.
• Development: Trilogy continues internal development at 3–5 campuses annually, leveraging value engineering and direct contracting to strip developer fees.

Market and Competitive Landscape:

• Executed $2.1 billion in external investments YTD across 17 senior housing communities; pipeline exceeds $1 billion.
• Two landmark deals closed: Kensington Senior Living portfolio ($572M closed, $873M total contract) and LCB Senior Living portfolio ($696M), establishing a Northeast footprint.
• Acquired assets feature an average vintage of 2019, located in affluent, supply-constrained "fortress" markets with high barriers to entry (e.g., LA, SF Bay Area, NYC, DC).
• Acquisitions were secured via relationships rather than price competition, often excluding the highest bidder in limited channels.
• Management views the current deal flow as robust, with industry volume running at 2x the previous year, and expects similar momentum in 2027.

Risks and Challenges:

• Political/Regulatory: Split Congress and White House expected to result in "business as usual" for skilled nursing regulation and reimbursement; no major expected changes.
• Asset Disposition: Non-core Outpatient Medical (OM) assets continue to be sold (reduced contribution from 35% to ~10% of NOI) to focus capital on REIT core engines.
• Liquidity: Swaps and term loan maturing in January 2027 are actively being refinanced; management maintains $1.3 billion in unsettled forward sales and $850 million credit line capacity.
• Operator Scaling: Risks of operators "going over their skis" by expanding too quickly; AHR strategically limits operator expansion to align with bench capacity.

Management Commentary and Tone:

• Tone is confident and assertive, emphasizing "measured aggression" and an integrated operating platform rather than just demographic tailwinds.
• CEO Jeff Hansen and COO Gabe Wilhite highlighted that "execution is the AHR advantage," citing the shift from occupancy-driven to rate-driven growth as a key differentiator.
• New CFO Eric Chang expressed strong alignment with the existing strategy, praising the team's execution and the balance sheet's strength.
• Management stressed that the company is "getting better, not just bigger," citing outperformance on acquisition underwritings (cap rate upside of ~75 bps) due to post-acquisition platform value-add.

Analyst Questions and Answers:

• Pipeline Quality: Confirmed deals remain high-quality, newer vintage, and relationship-sourced; strategy prioritizes existing trusted operators over broad geographic expansion with new partners.
• RevPOR Durability: Gabe Wilhite attributed RevPOR growth to structural platform advantages (revenue management playbooks from Trilogy, data analytics) rather than temporary comps; rent concessions dropped 34% YoY.
• Trilogy Margins: Controllable expense declines are primarily a one-time benefit from employee benefits optimization but reflect repeatable efficiency culture.
• Acquisition Pricing: Per-unit prices are higher due to asset quality, larger unit sizes (shift from studios to 1-2 bedrooms), and amenity-rich "fortress" markets, but remain below replacement cost.
• Capital Structure: No immediate plans for equity raises as the pipeline is fully funded; future raises will be match-funded to identified accretive investments.

Other Key Points:

• Transitioning to a "dynamic operating platform" that surrounds operators with resources (data, asset management, tech) to unlock value beyond base real estate performance.
• The "ShopPlus" portfolio now integrates multiple operators, with 11 operators (up from 8) and new leadership to support the scale.
• Trilogy's integrated campus model (skilled nursing + senior housing) creates natural seasonality hedging, allowing for consistent NOI growth despite revenue mix shifts.
• Emphasis on shifting industry metrics from "price per unit" to "price per square foot" and amenity value to reflect changing resident preferences for larger spaces.